Nicole Shonka

7PUBLICATIONS
113CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 09, 2024
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.

Isabel Arrillaga-Romany, Sharon L Gardner, Yazmin Odia

|Feb 01, 2023
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Letter.

Jonathan Q Trinh, Moataz Ellithi, Nicole Shonka

|Jan 13, 2023
Reconciling the Contemporary Molecular Diagnosis of Glioblastoma With Past Clinical Trial Data.

Nicole A Shonka, Craig M Horbinski

|Oct 26, 2022
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations.

Priscilla K Brastianos, Erin L Twohy, Elizabeth R Gerstner

|Mar 07, 2019
Evaluating the decisions of glioma patients regarding clinical trial participation: a retrospective single provider review.

Grant W Jirka, Karl Stessy M Bisselou, Lynette M Smith

Pageof 2